Background and objective: While has been well demonstrated that clinical charac-
| INTRODUC TI ON
Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies, affecting 5%-10% of women of reproductive age.
1
This complex endocrine disturbance is characterized by chronic oligo-ovulation or anovulation and hyperandrogenism (HA) resulting in infertility, menstrual irregularities, hirsutism, acne and alopecia.
2
PCOS is also associated with an increased risk of obesity, hyperinsulinemia, insulin resistance and long-term health implications, including type 2 diabetes mellitus and cardiovascular diseases 3 ; these signs and complications can lead to psychosocial and emotional disturbances and a decrease in their quality of life (QoL). 4, 5 Previous studies demonstrated the role of individual PCOS symptoms, including obesity, 6 infertility, 7 hirsutism, 8 HA 9 and insulin resistance 6 in the modulation of psychological aspects. Given the nature of these symptoms, it is to be expected that PCOS can have a negative impact on feminine identity of patients that leads to worsening different domains of QoL. 5 In fact, PCOS is associated with an increased risk of psychological disturbances and decreased sexual satisfaction, disturbances which can distribute to clinical and or biochemical disorders in these patients. 10 It is well known that a subjective evaluation of PCOS aspects in some girls might have a greater effect on their QoL, compared to the objective assessment. 11 While the relationship of clinical characteristics of PCOS with QoL is well documented, [12] [13] [14] it is unclear that whether biochemical aspects of PCOS can independently influence QoL in these patients.
In the present study, we aimed to evaluate the relationship between clinical and biochemical characteristics, and QoL of women with PCOS using a specific health-related quality-of-life questionnaire for PCOS patients.
| MATERIAL AND ME THODS

| Subject recruitment
In this cross-sectional study, we recruited 211 patients with PCOS and clinical and/or biochemical signs of HA.
2 Clinical HA is identified by hirsutism, acne and alopecia. 15 High levels of serum total testosterone (tT), free testosterone (fT), free androgen index (FAI), androstenedione (A4) and dehydroepiandrosterone sulphate (DHEAS) also indicate biochemical HA.
16
We excluded patients who had secondary aetiologies including hyperprolactinemia, thyroid dysfunction, Cushing syndrome, congenital adrenal hyperplasia and virilizing tumours. We also excluded patients with cardio-metabolic disorders such as diabetes, and cardiovascular or hepatic disease; all patients were nonsmokers and had negative pregnancy tests before enrolment. None of the women had been taking medications known to affect plasma sex steroids such as anti-androgens, hormonal contraceptives and insulin-sensitizing drugs for at least 3 months before the study.
| Clinical and anthropometric assessment
A trained midwife, expert in reproductive endocrinology, under supervision of a reproductive endocrinologist examined patients for anthropometric parameters, menstrual cycles, hirsutism and acne.
Patients were asked for demographic characteristics, history of infertility, duration of PCOS diagnosis and history of amenorrhea. Regularity of menstrual cycles was assessed in all patients.
According to FIGO recommendations, 17 patients who had intervals of menstrual cycle over 38 days were diagnosed as having infrequent menstrual bleeding, <24 days as frequent menstrual bleeding, and those with absence of menstrual periods for ≥6 months as amenorrhea. 18, 19 Modified Ferriman Gallwey (mFG) score was applied for determining the density of terminal hair at 9 different body sites, that is upper lip, chin, chest, upper back, lower back, upper abdomen, lower abdomen, arm and thigh; this scoring system grades excess terminal body or facial hair growth based on a scale of 0 (absence of terminal hairs) to 4 (frank virilization), and a total score of 8 or more were considered as hirsutism. 20 The severity of acne was determined using a grading system based on the number of lesions and their spread on the face, back and chest to classify it from mild to severe.
21
Patient weights were measured when they were minimally clothed using a digital scale (Seca 707, Seca GmbH, Hamburg, Germany) and rounded to the nearest 100 g. Height was measured without shoes in the standing position with shoulders in normal alignment, using a tape measure. Body mass index was calculated as weight in kilograms (kg) divided by height squared (m 2 ).
| Laboratory assessment
At baseline, fasting (at least 9 hours) blood samples were collected between days 3 and 5 of the spontaneous menstrual cycle or pro- 23 Intra-and interassay coefficients of variation (CV) were 2.2 and 2.9 for FBS, 1.2 and 3.1 for TG, 0.9 and 3.6 for TC, 1.4 and 2 for HDL cholesterol, 0.9 and 2.6 for LDL cholesterol, respectively.
| Quality-of-life assessment
We assessed QOL using a specific and valid health-related quality of life questionnaire for PCOS, developed by Nasiri-Amiri et al.
24
This questionnaire consisted of 43 items in five domains including psychosocial-emotional, fertility, sexual function and obesitymenstrual disorders. Items were scored based on the 5-point Likert scale (always, often, sometimes, rarely, never).
25
| Statistical analysis
Data of a total of 194 subjects were adequate to detect a correlation coefficient of 0.2 with a power of 80% and type one error of 5%.
Descriptive analysis has been presented as mean (SD) for continuous Statistical analysis was performed using stata software (version 10;
STATA, INC, College Station, TX); significance level was set at P < 0.05. are presented as Supporting Information Appendix S1. Table 3 illustrates mean QoL and its domains based on the different subgroups of age, BMI, marital status, fertility, hirsutism and insulin resistance. Mann-Whitney U test showed that mean QoL scores of patients aged ≥30 years were statistically significantly higher than those aged <30 years (P < 0.001). Married women had higher QoL scores compared to their single counterparts (P < 0.001).
| RE SULTS
Patients with a history of infertility obtained poorer scores of total QoL (P = 0.021) and its fertility domain (P < 0.001) than those without such history. Patients with insulin resistance obtained lower QoL scores in the domain of obesity-menstrual disorders (P = 0.044).
| D ISCUSS I ON
Although many studies have demonstrated that the clinical features of PCOS can deteriorate the patient's quality of life, it is unclear that whether biochemical aspects of this syndrome can influence their QoL. This study was undertaken to clarify the relationship between the clinical and biochemical characteristics and several domains of QoL in reproductive age women with PCOS using a specific healthrelated quality of life questionnaire designed for PCOS patients.
Our results showed a significant relationship between QoL and biochemical markers, in particular androgens and insulin resistance, in addition to the significant relationship between QoL and clinical manifestations of PCOS (obesity, hirsutism, menstrual intervals and infertility), associations which remained significant even after further adjustment for equivalent clinical manifestations.
In fact, many PCOS patients with clinical HA have increased circulating androgen levels, although in some of them, androgen levels are in normal ranges. It is well documented that the severity of HA symptoms correlate poorly with severity of androgen excess.
28
Given this obvious paradox, it is possible that androgen excess worsens QoL of patients with PCOS through direct effects of androgens on psycho-emotional aspects, in addition to its mediator effect in the appearance of clinical manifestations. Some studies showed 29, 30 significant correlations between psycho-emotional disorders such as depression and serum androgens. Social research suggests high androgen levels cause aggressive behavior in men and women, a consequence of which could be depression.
31
The present study showed significant relationships between QoL and some androgens including FAI and DHEAS levels, associations that remained significant even after adjustment for hirsutism, whereas QoL had no relationship with total testosterone, gonadotropins levels.
Although FAI was significantly related to the physical domains of QoL (hirsutism and obesity-menstrual disorders), we found no association between this androgenic marker and psych-emotional domains. Hence, our results suggest that increased available androgen levels have no additional psychological disturbances.
Interestingly, this study showed a significant positive relationship between DHEAS levels and the sexual domain of QoL in PCOS patients. However, there are complexities in the sexual aspect and its related factors in patients with PCOS. 32 Women with PCOS may feel that their sexual attraction is decreased and think that their partners are unsatisfied with their sexual relationships. Indeed, sexual function in these patients may be influenced by obesity, infertility, hirsutism, [33] [34] [35] acne, alopecia and hormonal disturbances. The role of androgenic levels in sexual function in patients with PCOS is not well known. 34 Davis et al 36 during a population based study of 1423 women, aged 18-75 years, found that among androgenic markers, only DHEAS was significantly related to sexual function; they did not detect any significant relationships between other androgens (serum total or free testosterone or androstenedione level) and sexual function. Although multiple psychosocial and physical factors contribute to low sexual desire and arousal, 37 it has been suggested that endogenous androgen levels are important determinants of sexual behavior in women. 38, 39 DHEA is the key precursor of the onward synthesis of androgens and estrogens, which may increase sexual function and well-being. [40] [41] [42] [43] Despite the above mentioned data, it should be considered that to confirm improving sexual function in PCOS patients with increased serum endogenous androgen levels, further studies are definitely needed. 36, 44 In this study, we hypothesized that dyslipidaemia is associated with impaired quality of life. The present study showed significant negative relationships of lipid parameters (TG, TC and LDL cholesterol) with the only physical domain of QoL (obesity-menstrual disorders); after adjustment for BMI, most correlations remained significant; it can be suggested that, in addition to obesity, other factors <0.001*
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HOMA-IR was also negatively related to some aspects of QoL, including psychosocial-emotional, self-image, fertility, sexual function and obesity-menstrual. Insulin resistance is one of the most common metabolic disorders in obese women with PCOS. The relationship between insulin and psychosocial-emotional aspects has been investigated by a few studies with conflicting results. [45] [46] [47] Depression is twofold in patients with diabetes compared to those without the disorders. 46 Although the exact mechanism of the insulin impact on mood changes and QoL has not yet been determined, it may be due to its role in neuro-cognitive functions. 45, 46 However, to determine the precise relationship between insulin resistance and psychosocial-emotional distress in PCOS women, further investigations are required. We found that after adjusting for BMI, the association of HOMA-IR with domains of QoL disappeared, a finding which highlights the intermediately role of obesity in the association between this QoL domain and insulin resistance.
In fact, numerous clinical features of PCOS may predispose to impaired QoL, including socio-demographic factors, weight gain and obesity, infertility and clinical hyperandrogenic symptoms. 33, 48 The relationship between socio-demographic factors (mainly age and marital status) and QoL is not well known, and previous stud- This study showed worsening QoL with increasing menstrual intervals; this relationship was significant only for the fertility domain of QoL. In accordance with our results, Li et al 56 found that patients with menstrual disturbances suffer from a great amount of stress, and they may be afraid of infertility due to their irregular menstrual cycles.
The present study also demonstrated that patients with a history of infertility had lowered QoL only for the fertility aspect. Although some studies 57,58 reported a higher prevalence of sexual disorders in infertile patients, we did not find any relationship between infertility and the sexual function domain of QoL.
To the best of our knowledge, this study is the first to compare the relationship between the clinical and biochemical characteristics of PCOS and QoL aspects. The main strengths of this study are using a specific and valid heath-related quality-of-life questionnaire for PCOS patients, measuring hormonal and metabolic parameters of PCOS and its correlations with QoL and performing subgroup analysis based on the most important determining factors of QoL such as age, BMI, hirsutism, history of infertility and insulin resistance. This study of course does have some limitations that should be considered in the interpretation of our results.
QoL in patients PCOS may be affected by various personal, social and emotional factors that could not been adjusted in present study. PCOS was diagnosed by AES criteria, which included the severe phenotype of PCOS, because of which patients with mild PCOS phenotypes were not assessed. We have used HOMA-IR as a surrogate marker for assessing of IR. In spite of the good correlation between HOMA-IR and gold standard clamp methods, 59 this method might be inaccurate in PCOS subjects.
60
| CON CLUS IONS
The present study confirmed the destructive impact of PCOS clinical and biochemical characteristics on several aspects of the patients' quality of life. Although biochemical disturbances can influence QoL of patients with PCOS, our results highlighted the role of clinical signs of PCOS such as obesity, infertility and hirsutism in deteriorating QoL.
Hence, clinicians should regularly assess the clinical and psychosocial dimensions of PCOS as well as biochemical aspects.
ACK N OWLED G EM ENTS
The authors thank Mrs. Niloofar Shiva for critical editing of English grammar and syntax of the manuscript.
CO N FLI C T O F I NTE R E S T
The authors have no conflicts of interest to declare.
O RCI D
Fahimeh Ramezani Tehrani https://orcid.
org/0000-0002-4609-065X 
R E FE R E N C E S
